reported that GTE decreased the phosphorylation of the NFκB p65 subunit and alleviated nonalcoholic steatohepatitis NASH in HF mice (Li et al., 2017). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatohepatitis.